Sygehusene i Næstved, Slagelse og Ringsted

Medicin og biovidenskab

1. Denmark 100%
2. Knee Osteoarthritis 97%
3. Randomized Controlled Trials 74%
4. Systematic Reviews 61%
5. Cohort Studies 59%
6. Knee Replacement Arthroplasties 58%
7. Exercise Therapy 54%
8. Exercise 51%
9. Hip Osteoarthritis 51%
10. Pain 51%
11. Asthma 47%
12. Chronic Obstructive Pulmonary Disease 45%
13. Type 2 Diabetes Mellitus 42%
14. Knee 40%
15. Meta-Analysis 38%
16. Osteoarthritis 37%
17. Multimorbidity 35%
18. Therapeutics 34%
19. Mortality 34%
20. Population 32%
21. Neuromyelitis Optica 32%
22. Prospective Studies 32%
23. Quality of Life 31%
24. Arthroplasty 31%
25. Hip 31%
26. Registries 28%
27. Rehabilitation 28%
28. Child 28%
29. Confidence Intervals 27%
30. Observational Studies 27%
31. Pregnancy 26%
32. Cardiac Rehabilitation 24%
33. Placebos 23%
34. Lung 23%
35. Patient Education 23%
36. Coronavirus 23%
37. Cross-Sectional Studies 22%
38. Education 21%
39. Health 20%
40. Comorbidity 20%
41. Optic Neuritis 20%
42. Delivery of Health Care 19%
43. Incidence 18%
44. Guidelines 17%
45. Multicenter Studies 17%
46. Stroke 17%
47. Hospital Emergency Service 17%
48. Intensive Care Units 16%
49. Odds Ratio 16%
50. Dexamethasone 16%
51. Mothers 15%
52. Feasibility Studies 15%
53. Self-Management 15%
54. Heart Failure 15%
55. Knee Injuries 14%
56. Lung Neoplasms 14%
57. Suburban Population 14%
58. Referral and Consultation 13%
59. Anti-Bacterial Agents 13%
60. Acetaminophen 13%
61. Databases 13%
62. Fish Oils 13%
63. Adrenal Cortex Hormones 12%
64. Chronic Pain 12%
65. Hospitalization 12%
66. Primary Health Care 12%
67. Microbiota 12%
68. Hypothyroidism 12%
69. Neoplasms 12%
70. Health Care Outcome Assessment 12%
71. Magnetic Resonance Imaging 11%
72. Inflammatory Bowel Diseases 11%
73. Hermeneutics 11%
74. Iron 11%
75. Colorectal Neoplasms 11%
76. empagliflozin 11%
77. Transferrin 11%
78. Hypersensitivity 11%
79. Azithromycin 11%
80. Idiopathic pulmonary hemosiderosis 10%
81. Life Style 10%
82. Rheumatoid Arthritis 10%
83. Postoperative Pain 10%
84. Dyspnea 10%
85. Ibuprofen 10%
86. Vitamin D 10%
87. Interviews 10%
88. Infections 10%
89. Physical Therapists 10%
90. Cardiovascular Diseases 10%
91. Caregivers 10%
92. Gastrointestinal Microbiome 10%
93. Multiple Sclerosis 10%
94. Analgesics 10%
95. Early Warning Score 9%
96. Physiologic Monitoring 9%
97. Patient Reported Outcome Measures 9%
98. Emergencies 9%
99. Tears 9%
100. Length of Stay 9%